about
Sirukumab: a promising therapy for rheumatoid arthritis.A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor.ABP 501 for the treatment of rheumatoid arthritis.Transfusion-related acute lung injury in a patient with systemic lupus erythematosus.Golimumab for Rheumatoid ArthritisElectrocardiographic Manifestations in three Psychiatric patients with Hypothermia - Case ReportHydroxychloroquine-induced dark butterfly rash in a rheumatoid arthritis patientTreatment strategies are more important than drugs in the management of rheumatoid arthritisGranuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based reviewUnmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university centerEtanercept biosimilar SB-4Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findingsUnmet needs in the treatment of ankylosing spondylitis: a long-term observational study from a single university centerRheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs?Adalimumab-induced myasthenia gravis: case-based reviewRadiological Findings of the Cervical Spine in Rheumatoid Arthritis: What a Rheumatologist Should KnowThe lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk
P50
Q38856800-42AAA0CA-7399-4903-B598-C94203967FB7Q47129016-5D66A505-4770-4A8B-9F5F-532DD3A63B69Q48208578-5909B179-1F21-4F58-BE67-D9C4E46C1F90Q50925452-C69C3A80-BC38-4895-97AF-9AB28BED80F7Q64071171-ECFC0CD7-5168-49BF-97DD-92C36EEC89CDQ88624837-F3EE3628-F57C-4C95-911A-0EB9DB2AAE2DQ89781685-126A6B96-EDC2-44C0-8B5A-2D9DB0D98723Q89845978-91EAA6A9-6748-496B-92D8-2282EE7D98E9Q90318979-07442075-4441-4905-AAD2-A287BD27A948Q90745397-2B2D2EBF-2BF2-4D01-BAB4-CBED39C63172Q90925509-66D7B1F1-C59F-473B-888C-CFE0A85D196BQ92231641-997777D7-8EC5-4D63-A9E0-508E7CAE2E2DQ92403999-6ED8C36A-B41D-4F24-9CED-A28287C670D5Q92702522-D9E6172E-F52B-4342-8954-050A54FA811BQ93169169-8B753962-2B99-4AB5-BD77-D0DCC12FD0FAQ94674717-4B62F48C-1812-4F0D-9ECD-0625937F99EAQ96307436-3C3940FE-F4C3-4341-AB3C-0376FF2AE9E8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eleftherios Pelechas
@ast
Eleftherios Pelechas
@en
Eleftherios Pelechas
@es
Eleftherios Pelechas
@nl
type
label
Eleftherios Pelechas
@ast
Eleftherios Pelechas
@en
Eleftherios Pelechas
@es
Eleftherios Pelechas
@nl
prefLabel
Eleftherios Pelechas
@ast
Eleftherios Pelechas
@en
Eleftherios Pelechas
@es
Eleftherios Pelechas
@nl
P106
P1153
55625101700
P31
P496
0000-0002-9383-5722